TD Asset Management Inc Has $132.42 Million Stake in Agilent Technologies, Inc. $A

TD Asset Management Inc lowered its position in Agilent Technologies, Inc. (NYSE:A) by 2.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 996,884 shares of the medical research company’s stock after selling 26,544 shares during the period. TD Asset Management Inc’s holdings in Agilent Technologies were worth $132,416,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in shares of Agilent Technologies by 4.3% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock worth $82,712,000 after acquiring an additional 24,687 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Agilent Technologies by 20.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company’s stock valued at $7,269,000 after purchasing an additional 9,236 shares during the last quarter. Crossmark Global Holdings Inc. grew its stake in shares of Agilent Technologies by 39.6% during the fourth quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock valued at $4,615,000 after purchasing an additional 9,615 shares during the last quarter. Dudley & Shanley Inc. increased its holdings in shares of Agilent Technologies by 25.9% in the second quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock valued at $9,232,000 after purchasing an additional 14,300 shares in the last quarter. Finally, Capricorn Fund Managers Ltd acquired a new stake in shares of Agilent Technologies in the first quarter valued at approximately $8,161,000. 87.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on A shares. Barclays increased their price objective on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research report on Wednesday, June 24th. Robert W. Baird boosted their target price on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 26th. Jefferies Financial Group began coverage on Agilent Technologies in a research note on Thursday, July 9th. They set a “hold” rating and a $135.00 price target on the stock. Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Finally, Wells Fargo & Company lowered their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Price Performance

Shares of A opened at $148.55 on Friday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27. The stock has a market cap of $41.96 billion, a P/E ratio of 29.83, a price-to-earnings-growth ratio of 2.64 and a beta of 1.25. The stock’s 50-day moving average price is $135.38 and its two-hundred day moving average price is $125.56.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. The company had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.Agilent Technologies’s revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities analysts predict that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were issued a $0.255 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.